Beginner's Mind

Most founders add layers to gain control. Reed Hastings built an empire by removing them. 

This episode unpacks No Rules Rules—the leadership playbook behind Netflix’s rise from a DVD mail service to a global entertainment powerhouse. Co-authored by founder Reed Hastings and INSEAD professor Erin Meyer, the book reveals how to scale not through policy, but through trust, talent density, and extreme transparency. 

But this isn’t just ...

 Most cancer drugs fail. Not because the science is wrong—because we’re solving the wrong problems.

The cost? Over $2 billion per failure. And for the patient waiting on a miracle—there’s no second chance.

Behind the headlines of “precision medicine,” there’s a deeper story nobody’s telling. Until now. 

🎯 Enter Rafael Rosengarten, the scientist-turned-founder who’s rewriting the rules of drug development.

Europe has the science. The talent. The breakthroughs.

But when an idea feels too uncertain, our systems shut it down before it has a chance to breathe.

And with every safe bet… we quietly lose the next cure, the next Car-T, the next AI that could change everything. 

🚨 Risk-aversion, fragmentation, and bureaucracy are draining Europe’s innovation power—and nobody dares to name it out loud.

But Fabrizio Conicella, VP of Open Innovation...

What if the only way to save the planet... is to cool it?
Not figuratively—literally.
Because the heatwaves, floods, and fires you’ve seen so far? They’re just the beginning.

🌍 Emissions keep rising. Global cooperation is slowing. And the window to act is closing fast.
 Now, world leaders are quietly weighing a radical idea: Should we artificially cool Earth before it’s too late?

💥 In this explosive episode, we dive i...

What if your business ran like a well-designed machine—one that could evolve, self-correct, and outperform your competition over decades?

In this episode, I unpack Principles by Ray Dalio, the billionaire investor and founder of Bridgewater Associates, the world’s largest hedge fund. It’s not a traditional business book—it’s a blueprint for decision-making, culture design, and long-term scaling, rooted in clarity, transparency, and ...

What does it take to turn extreme adversity into extraordinary leadership? Suzanne Heywood’s life reads like a novel—shipwrecked at seven, isolated at sea for a decade, forging her father’s signature to survive, and ultimately earning a place at Oxford through sheer determination. Today, she’s a top executive and investor, steering multi-billion-dollar companies with resilience, clarity, and innovation.

In this episode, Suzanne shar...

ATMPs, gene therapies, and cancer breakthroughs are here—but outdated regulations, high costs, and logistical bottlenecks are blocking access. What needs to change for hospitals to deliver these cures to patients who need them most?

💡 Here’s the harsh reality:

• Patients are waiting, but hospitals aren’t ready.
• The science exists, but regulations haven’t caught up.
• The treatments work, but they’re too expensive to scale.

So what...

In 2021, biotech IPOs were soaring. Valuations hit record highs. Investors were throwing money at anything that moved.

Then… the market crashed. Funding dried up. Growth stalled. Biotech founders and investors were left scrambling.

So what really happened? And more importantly—how do you navigate what’s next?

📌 In this episode, Christopher Uhde—Senior Pharma & Biotech Equity Analyst at SEB—breaks down the brutal realities of biot...

🚀 Most investors chase consensus. The best ones? They bet against it.

If everyone agrees on an investment, it’s probably not bold enough. That’s why the greatest venture capitalists don’t just follow trends—they seek out the hidden outliers that redefine industries. But how do they spot the next Amazon, Google, or Tesla before anyone else? And why do so many leaders play it safe and miss out?

📌 In this episode, Alex Dang—former Ama...

What if your greatest asset in business was how you think under pressure?

In this episode, I dive into The Venture Mindset by Alex Dang and Ilya Strebulaev, unpacking seven transformative lessons drawn from the world of venture capital and deep-tech entrepreneurship. These principles aren’t just for investors—they’re a roadmap for anyone navigating uncertainty, from startup founders to corporate innovators.

Alex Dang, a veteran innov...

What does it take to redefine venture capital while empowering founders to disrupt industries and drive meaningful change? Meet Dan Bowyer, a bold investor from Superseed VC reshaping the game with a no-nonsense approach and a passion for impactful innovation.

In this episode, Dan shares his journey from entrepreneur to VC and dives deep into what’s wrong with traditional venture capital. He reveals the personality traits that defin...

What makes a year unforgettable? Is it the challenges conquered, the bold ideas pursued, or the connections that shaped us?

As 2024 comes to a close, this special episode celebrates the lessons, breakthroughs, and visionary insights that defined the year. Through 9 remarkable stories, hear from leaders, investors, and innovators who are shaping the future.

🎙️ In This Episode:

• Suzanne Heywood: Discover the balance of trust and cha...

Our global food systems are at a breaking point. Climate change, geopolitical tensions, and industrial farming are pushing us closer to food insecurity every day. Can we find a way to feed 10 billion people while safeguarding the planet?

Marina Schmidt, founder of Red to Green Solutions, reveals groundbreaking ideas that reimagine how we grow, consume, and sustain food for a resilient future.

🎙️ What’s in the Episode:
1️⃣ Build...

What does it take to tackle the world's biggest challenge—climate change—while driving profit and innovation? Meet Doerte Hirschberg, a visionary investor reshaping industries with bold ideas and data-driven solutions.

In this episode, Doerte takes us on a journey of how her team at Climentum Capital uses measurable CO2 impact as their guiding star. She shares insights into why the future of sustainable industries lies in rethi...

What if your greatest advantage in business was how you think about the future?

In this episode, I explore Richer, Wiser, Happier by William Green, unpacking seven actionable lessons inspired by legendary investors like Warren Buffett, Charlie Munger, and Sir John Templeton. These lessons go beyond money—they’re about mastering long-term thinking, simplifying complexity, and building resilience to thrive in uncertainty.

William Green...

What does it take to lead a global biotech company tackling diseases like cancer and Alzheimer’s—and still treat every team member, from executives to production staff, as equals?

In this 20-minute highlight episode, we meet Philipp Baaske, the visionary CEO of NanoTemper. From his small Bavarian village roots to global biotech innovation, Philipp shares the leadership lessons and personal philosophies that shaped his journey.

Quotes...

Startups promise innovation, but why do so many fail to secure the funding they need?

Investors demand results before committing, yet startups require resources to build. This paradox leaves founders stuck in what angel investor DC Palter calls the "pit of hell." How can startups navigate this critical gap and convince investors to bet on their vision?

🎙️ What's in the Episode:
1️⃣ Cracking the Funding Code: Lear...

Europe’s biotech sector is facing a crisis: despite its scientific achievements, it struggles with funding gaps and an exodus of top talent to the US. As biotech innovations drive global healthcare, Europe risks losing its edge—and the potential for groundbreaking medical advancements that affect us all. How can Europe regain its competitive advantage and transform scientific discoveries into real-world solutions?

In this special ep...

Healthcare investment is booming, but why do so few initiatives actually deliver lasting impact? While funding flows into biotech and life sciences, many leaders overlook the complex strategies needed to bridge research and real-world application. Are you ready to discover the key to successful healthcare innovation and make informed decisions that truly drive change?

In this episode, Shlomo Noy, a pioneer in biotech investment and ...